Hemato Oncology
Medical Oncology Center
Chemotherapy
,
Breast cancer
,
Clinical trial
,
Personalized treatment
Breast cancer
,
Clinical trial
,
Personalized treatment
Education / Career
| Article | Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. | ||
|---|---|---|---|
| Announcements | BMC Cancer | Date of publication | 2015 |
| Co-researcher | Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ. | ||
| Article | Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy. | ||
|---|---|---|---|
| Announcements | Nutr Cancer | Date of publication | 2016 |
| Co-researcher | Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ. | ||
| Article | Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer. | ||
|---|---|---|---|
| Announcements | Breast Cancer Res Treat | Date of publication | 2016 |
| Co-researcher | Suh KJ, Ryu HS, Lee KH, Kim H, Min A, Kim TY, Yang Y, Moon HG, Han SW, Oh DY, Han W, Park IA, Noh DY, Im SA | ||
| Article | Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database. | ||
|---|---|---|---|
| Announcements | BMC Cancer | Date of publication | 2016 |
| Co-researcher | Shin S, Park CM, Kwon H, Lee KH. | ||
| Article | TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials. | ||
|---|---|---|---|
| Announcements | Br J Cancer | Date of publication | 2016 |
| Co-researcher | Lee DW, Jang MJ, Lee KH, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yoon JH, Kim TY, Han SW, Oh DY, Im SA, Kim TY. | ||